Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Biomind reports in vivo findings with DMT combination drug BMND-07

March 4, 2022

Targeting alpha2-Na+/K+ ATPase improves tau pathology in vivo

March 4, 2022

PMN-310 shows cognitive benefit in mouse model of Alzheimer's disease

March 3, 2022

Ruhr University Bochum presents new compounds for treating axonal damage

March 3, 2022

Neuropathy may unify disparate long COVID symptoms

March 2, 2022

Quanterix collaborates with Lilly on diagnosis and treatment of Alzheimer's disease

March 2, 2022

Complement factor B inhibitors discovered at Shanghai Meiyue Biotech Development

March 2, 2022

Study finds potential entry points to Huntington's therapy

March 1, 2022

Fibulin-2 as a novel therapeutic target in multiple sclerosis

March 1, 2022

Murine model reveals aging to promote autoimmune encephalomyelitis with meningeal inflammation

Feb. 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...